These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38462034)

  • 1. Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.
    Weidner P; Saar D; Söhn M; Schroeder T; Yu Y; Zöllner FG; Ponelies N; Zhou X; Zwicky A; Rohrbacher FN; Pattabiraman VR; Tanriver M; Bauer A; Ahmed H; Ametamey SM; Riffel P; Seger R; Bode JW; Wade RC; Ebert MPA; Kragelund BB; Burgermeister E
    Cancer Lett; 2024 Apr; 588():216783. PubMed ID: 38462034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotubularin related protein 7 is essential for the spermatogonial stem cell homeostasis via PI3K/AKT signaling.
    Zhao D; Shen C; Gao T; Li H; Guo Y; Li F; Liu C; Liu Y; Chen X; Zhang X; Wu Y; Yu Y; Lin M; Yuan Y; Chen X; Huang X; Yang S; Yu J; Zhang J; Zheng B
    Cell Cycle; 2019 Oct; 18(20):2800-2813. PubMed ID: 31478454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer.
    Weidner P; Söhn M; Gutting T; Friedrich T; Gaiser T; Magdeburg J; Kienle P; Ruh H; Hopf C; Behrens HM; Röcken C; Hanoch T; Seger R; Ebert MP; Burgermeister E
    Oncotarget; 2016 Aug; 7(31):50490-50506. PubMed ID: 27409167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma.
    Weidner P; Söhn M; Schroeder T; Helm L; Hauber V; Gutting T; Betge J; Röcken C; Rohrbacher FN; Pattabiraman VR; Bode JW; Seger R; Saar D; Nunes-Alves A; Wade RC; Ebert MPA; Burgermeister E
    Oncogenesis; 2020 Jun; 9(6):59. PubMed ID: 32522977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9.
    Mochizuki Y; Majerus PW
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9768-73. PubMed ID: 12890864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing myotubularin related protein 7 enhances proliferation and early differentiation of C2C12 myoblast.
    Yuan Z; Chen Y; Zhang X; Zhou X; Li M; Chen H; Wu M; Zhang Y; Mo D
    Biochem Biophys Res Commun; 2017 Mar; 484(3):592-597. PubMed ID: 28153733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotubularin regulates Akt-dependent survival signaling via phosphatidylinositol 3-phosphate.
    Razidlo GL; Katafiasz D; Taylor GS
    J Biol Chem; 2011 Jun; 286(22):20005-19. PubMed ID: 21478156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the EGFR-RAS Inhibitory Proteins DOK1 and MTMR7 and its Significance in Colorectal Adenoma and Adenoma Recurrence.
    Gutting T; Merkel A; Fink DJ; Hetjens S; Weidner P; Yu Y; Kähler G; Ebert MP; Gaiser T; Burgermeister E; Belle S
    J Gastrointestin Liver Dis; 2021 Dec; 30(4):446-455. PubMed ID: 34941983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting ERK1/2 protein-serine/threonine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2019 Apr; 142():151-168. PubMed ID: 30794926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V; Scott RP; Ibáñez CF
    J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis.
    Hu L; Liang S; Chen H; Lv T; Wu J; Chen D; Wu M; Sun S; Zhang H; You H; Ji H; Zhang Y; Bergholz J; Xiao ZJ
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E3964-E3973. PubMed ID: 28468801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-Ras
    Zhang J; Liu W; Dong H; Wang W
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2048-2057. PubMed ID: 31126199
    [No Abstract]   [Full Text] [Related]  

  • 13. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
    Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
    Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity.
    Elad-Sfadia G; Haklai R; Balan E; Kloog Y
    J Biol Chem; 2004 Aug; 279(33):34922-30. PubMed ID: 15205467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-Raf co-operates with PI3K-dependent signalling and critically contributes to myeloma cell survival independently of mutated RAS.
    Müller E; Bauer S; Stühmer T; Mottok A; Scholz CJ; Steinbrunn T; Brünnert D; Brandl A; Schraud H; Kreßmann S; Beilhack A; Rosenwald A; Bargou RC; Chatterjee M
    Leukemia; 2017 Apr; 31(4):922-933. PubMed ID: 27686868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors.
    Jaiswal BS; Janakiraman V; Kljavin NM; Eastham-Anderson J; Cupp JE; Liang Y; Davis DP; Hoeflich KP; Seshagiri S
    PLoS One; 2009 May; 4(5):e5717. PubMed ID: 19492075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY-142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines.
    Balmanno K; Chell SD; Gillings AS; Hayat S; Cook SJ
    Int J Cancer; 2009 Nov; 125(10):2332-41. PubMed ID: 19637312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status.
    Kimple RJ; Vaseva AV; Cox AD; Baerman KM; Calvo BF; Tepper JE; Shields JM; Sartor CI
    Clin Cancer Res; 2010 Feb; 16(3):912-23. PubMed ID: 20103665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway.
    Blondeau F; Laporte J; Bodin S; Superti-Furga G; Payrastre B; Mandel JL
    Hum Mol Genet; 2000 Sep; 9(15):2223-9. PubMed ID: 11001925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.
    Ebi H; Corcoran RB; Singh A; Chen Z; Song Y; Lifshits E; Ryan DP; Meyerhardt JA; Benes C; Settleman J; Wong KK; Cantley LC; Engelman JA
    J Clin Invest; 2011 Nov; 121(11):4311-21. PubMed ID: 21985784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.